| 摘要 |
<p>The invention concerns in particular a combination product comprising at least a compound having affinity for the benzodiazepine mitochondrial receptor and at least an apoptosis-inducing agent for simultaneous, separate or sustained use, for treating cancer. The invention also concerns the use of said compound and/or said combination product for making a medicine particularly for facilitating apoptosis induction.</p> |
